Group B strep (GBS) is not a sexually transmitted disease. It is a bacterium commonly found in the digestive, urinary, and reproductive tracts of healthy adults, particularly pregnant people. While it can be passed to a baby during childbirth, transmission occurs through colonization, not sexual contact.
GBS is a normal inhabitant of the human microbiome in many individuals. It does not meet the criteria for an STD because it is not acquired through sexual activity. The Centers for Disease Control and Prevention (CDC) classifies GBS as a condition related to maternal carriage and vertical transmission, not sexual transmission.
Despite frequent confusion, GBS is not spread via intercourse, nor does it require treatment in partners. Its presence in the birth canal poses a risk only to newborns during delivery, not to sexual partners. This distinction is critical for accurate health communication and prevention strategies.
Group B strep (Streptococcus agalactiae) lives harmlessly in the gastrointestinal and genitourinary tracts of about 25% of healthy adults. Carriage is often asymptomatic, meaning carriers feel no illness. The bacteria can colonize the rectum, vagina, or urethra without causing symptoms.
During labor, if a pregnant person tests positive for GBS, the bacteria can ascend into the uterus and infect the baby during passage through the birth canal. The infant's immature immune system cannot handle the exposure, leading to early-onset disease within the first week of life.
Transmission is not dependent on sexual activity. A woman can carry GBS regardless of her sexual history. Studies show that GBS colonization rates remain stable across populations, indicating environmental or individual microbial balance factors rather than infectious behavior.
Group B strep is a Gram-positive, beta-hemolytic bacterium. It forms chains under the microscope and produces hemolysin, which destroys red blood cells. It belongs to Lancefield group B, a classification based on cell wall carbohydrate antigens.
Detection relies on vaginal and rectal swabs collected between 35 and 37 weeks of gestation. The sample is cultured on selective media such as Granada medium or chromogenic agar. Results take 24-48 hours. A positive result indicates carrier status, not active infection.
Testing is standard in U.S. obstetric care. The American College of Obstetricians and Gynecologists (ACOG) recommends universal screening because early-onset GBS disease affects approximately 1 in 200 live births without intervention. Penicillin administered during labor reduces transmission risk by 80%.
Many assume GBS is an STD because it resides in the genital tract and is tested during prenatal visits. However, this location does not equate to sexual transmission. The CDC explicitly states that GBS is not transmitted through sex and is not included in routine STI panels.
Another misconception is that GBS causes long-term illness in adults. In healthy individuals, GBS carriage causes no symptoms. When disease occurs, it typically affects newborns, elderly adults, or those with weakened immunity. In rare cases, GBS can cause bloodstream infections or meningitis in adults, but these are not linked to sexual contact.
A key distinction: while gonorrhea and chlamydia are confirmed STDs with clear sexual transmission routes, GBS is not. The bacteria spreads through close contact, environmental exposure, or existing colonization-not through sexual activity.
GBS infections fall into two categories: early-onset (within first 7 days) and late-onset (after 7 days). Early-onset disease is the primary concern during childbirth. Late-onset disease may occur weeks later and is often associated with respiratory or central nervous system involvement.
| Type | Onset | Common Manifestations | Transmission Route |
|---|---|---|---|
| Early-onset | Within 1st week | Sepsis, pneumonia, meningitis | Vertical (birth canal) |
| Late-onset | 7 days - 3 months | Meningitis, sepsis, joint infections | Unknown; possibly environmental or person-to-person |
Neonatal GBS meningitis has a mortality rate of 5-10% and a 30% chance of long-term neurodevelopmental impairment. These outcomes show the importance of screening and intrapartum antibiotic prophylaxis.
In 2019, a 32-year-old pregnant woman in California tested positive for GBS at 36 weeks. She had no prior history of STIs and was in a monogamous relationship. Her partner was tested for common STIs and found negative. The couple assumed GBS was an STI and experienced significant anxiety.
After consulting her OB-GYN, she learned that GBS is not sexually transmitted. The doctor explained that her positive test result indicated colonization, not infection, and that penicillin during labor would prevent transmission to her baby. She delivered vaginally and her newborn remained healthy.
This case illustrates how misinformation leads to unnecessary distress. The CDC reports that over 40% of patients incorrectly believe GBS is an STI, despite public education efforts.
GBS is often confused with Group A strep (GAS), which causes strep throat and skin infections. GAS is a different species (Streptococcus pyogenes) and is transmitted through respiratory droplets. It is not associated with pregnancy-related risks or neonatal disease.
The confusion stems from terminology. "Strept" sounds similar to "STD," and GBS is tested during prenatal visits alongside STIs. This proximity creates false associations., some online forums and social media posts incorrectly label GBS as an STI.
Medical professionals emphasize that GBS is a colonization issue, not an infectious disease in the sexual transmission sense. The World Health Organization (WHO) includes GBS in its list of priority pathogens for vaccine development due to its impact on newborns, not because it spreads sexually.
Understanding that group B strep is not an STD prevents stigma, reduces anxiety, and ensures appropriate care. For women expecting a child, knowing the difference supports informed decisions about screening and treatment.
Group B strep is not an STD. It is a common bacterium carried by healthy adults, especially during pregnancy. Its transmission to newborns happens during labor, not through sex. Proper screening and intrapartum antibiotics have reduced early-onset GBS disease by over 80% since 1990. If you're pregnant, testing for group B strep is standard. If you're concerned about postpartum risks, monitoring for signs of infection after delivery is recommended.